enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lorcaserin - Wikipedia

   en.wikipedia.org/wiki/Lorcaserin

   Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus , a region of the brain which is known to control appetite. [ 6 ]

3. 25 Belt-Busting Obesity Facts - AOL

   www.aol.com/2013/05/18/25-belt-busting-obesity-facts

   The Food and Drug Administration approved the weight-loss therapy Belviq from Arena Pharmaceuticals in June 2012. It took nearly one year for the company to gain marketing approval, but Belviq's ...

4. Cheaper Obesity Drugs Available (for Half of Some Americans)

   www.aol.com/news/2014-02-24-cheaper-obesity...

   For premium support please call: 800-290-4726 more ways to reach us

5. 5 new weight-loss drugs to watch in the fight for the next ...

   www.aol.com/5-weight-loss-drugs-watch-104701179.html

   GLP-1 medications are breakthroughs for weight loss, diabetes, and more. Pharma companies are clamoring to produce pills or longer-lasting drugs with faster effects. Novo Nordisk, Eli Lilly ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.

7. Obesity-Drug Smackdown - AOL

   www.aol.com/2012/07/18/obesity-drug-smackdown

   VIVUS (NAS: VVUS) gained Food and Drug Administration approval yesterday for its new obesity drug, Qsymia, which will compete directly with Arena Pharmaceuticals' (NAS: ARNA) recently approved Belviq.